Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and sklb1002

quinazolines has been researched along with sklb1002 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cao, Z; Cheng, L; Dai, L; Deng, H; Deng, S; Feng, S; Li, W; Liu, S; Liu, Y; Ma, Y; Pan, Y; Shen, G; Shi, S; Tian, H; Wang, W; Wei, Y; Xie, H; Yang, S; Yang, Y; Zhang, N; Zhang, S; Zhao, C; Zhao, X; Zheng, R1
Gao, X; Li, YL; Liu, XX; Ma, XL; Nie, W; Sang, YX; Shen, GB; Shi, HS; Wang, FT; Wei, YQ; Xu, GC1
Fu, LX; Tang, DM; Wang, Y; Yan, HX; Yang, XN1
Jiang, Q; Li, JJ; Li, XM; Lu, C; Tao, SY; Yan, B; Yao, J; Zhang, QY1

Other Studies

4 other study(ies) available for quinazolines and sklb1002

ArticleYear
SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-01, Volume: 17, Issue:13

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Hep G2 Cells; Humans; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Quinazolines; Signal Transduction; Thiadiazoles; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish

2011
Synergic antitumor effect of SKLB1002 and local hyperthermia in 4T1 and CT26.
    Clinical and experimental medicine, 2014, Volume: 14, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Female; Histocytochemistry; Hyperthermia, Induced; Immunohistochemistry; Mice, Inbred BALB C; Necrosis; Platelet Endothelial Cell Adhesion Molecule-1; Quinazolines; Thiadiazoles; Treatment Outcome

2014
A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis.
    Molecular medicine reports, 2013, Volume: 8, Issue:2

    Topics: Animals; Capillary Permeability; Disease Models, Animal; Inflammation; Mice; Mice, Transgenic; Neovascularization, Pathologic; Psoriasis; Quinazolines; Skin; T-Lymphocytes; Thiadiazoles; Vascular Endothelial Growth Factor Receptor-2

2013
SKLB1002, a potent inhibitor of VEGF receptor 2 signaling, inhibits endothelial angiogenic function in vitro and ocular angiogenesis in vivo.
    Molecular medicine reports, 2020, Volume: 21, Issue:6

    Topics: Animals; Burns, Chemical; Cell Movement; Cell Proliferation; Cornea; Corneal Diseases; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred ICR; Neovascularization, Physiologic; Ophthalmic Solutions; Quinazolines; Signal Transduction; Thiadiazoles; Vascular Endothelial Growth Factor Receptor-2

2020